Nuvalent
targeted therapies for patients with cancer | Nuvalent
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
39 of 40
Related slides by other companies
Kiromic BioPharma
Investor Presentation
May 2023
cell therapy multiple potential indications non viral non non viral non engineered engineered off the shelf off the shelf product product candidate candidate targeting stress targeting stress on on cancer cells cancer cells | Kiromic BioPharma
BioNTech
Results
August 2021
disease horizon expanding the application spectrum of our technology grow mature novel technologies across oncology infectious diseases and beyond | BioNTech
Fusion Pharmaceuticals
Investor Presentation
November 2023
resurgence | Fusion Pharmaceuticals
TScan Therapeutics
IPO
July 2021
learning from patients who are winning their fight against cancer | TScan Therapeutics
Other recent decks by Nuvalent
See all presentations (10 decks)
Investor Presentation
April 2024
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights